- DeMario, M.D. and Leibovitz, D.N. (1998) "Lymphomas in the immunocompromized patient", Semin. Oncol. 25, 492-502.
- Levine, A.M., Seneviratne, L., Aspina, B.M., Wohl, A.R., Tulpule, A., Nathwani, B.N. and Gill, P.S. (2000) "Evolving characteristics of AIDS-related lymphoma", Blood 96, 4084-4090.
- Grillo-Lopez, A.J. (2000) "Rituximab: an insider's historical perspective", Semin. Oncol. 27(Suppl. 12), 9-16.
- Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., and Gisselbrecht, C. (2002) "CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma", N. Engl. J. Med. 346(4), 235-242.
- Milpied, N., Vasseur, B., Parquet, N., Garnier, J.L., Antoine, C., Quartier, A.S., Bouscary, D., Faye, A., Bourbigot, B., Reguerre, Y., Stoppa, A.M., Hurault de Ligny, B., Dubief, F., Mathieu-Boue, A. and Leblond, V. (2000) "Humanized anti-CD20 monoclonal antibody (Rituximab) in transplant B-lymphoproliferative disorder: a retrospective study on 32 patients", Ann. Oncol. 11, 113-116.
- Treon, S.P., Agus, D.B., Link, B., Rodrigues, G., Molina, A., Lacy, M.Q., Emmanouilides, C., Richards, A.I., Clark, B., Lucas, M.S., Schlossman, R., Schenkein, D., Lin, B., Kimby, E., Anderson, K.C. and Byrd, J.C. (2001) "CD20-directed antibody-mediated immunotherapy induced resoponses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia", J. Immunother. 24, 272-279.
- Shvidel, L., Klepfish, A. and Berrebi, A. (2001) "Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma", Am. J. Hematol. 67, 213-214.
- Cohen, Y., Polliack, A., Zelig, O. and Goldfarb, A. (2001) "Monotherapy with Rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma", Leuk. Lymphoma 42, 1405-1408.
- Wilson, W.H. (2000) "Chemotherapy sensitization by Rituximab: experimental and clinical evidence", Semin. Oncol. 27(Suppl. 12), 30-36.
- Sweetenham, J., Hieke, K., Kerrigan, M., Howard, P., Smartt, P.F., McIntosh, G. and Townshend, S. (1999) "Cost-minimization analysis of CHOP, fludarabine and Rituximab in the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K.", Br. J. Haematol. 106, 47-54.
- Perez, C.L. and Rudoy, S. (2001) "Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient", Clin. Diagn. Lab. Immunol. 8. 993-996.
Successful Treatment of Aggressive HIV-associated Non-Hodgkin's Lymphoma with Combination Chemotherapy, Biotherapy with Rituximab and HAART: Presentation of a Therapeutic Option
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.